Anesthetic Management for a Patient with Charcot-Marie-Tooth Disease Using Propofol and Rocuronium.
10.4097/kjae.2003.44.5.721
- Author:
Hyun Jeong KWAK
1
;
Seung Muk HAN
;
Dal Yong KIM
;
Ho Sung KWAK
Author Information
1. Department of Anesthesia and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea. hyun615@hanmail.net
- Publication Type:Case Report
- Keywords:
Charcot-Marie-Tooth disease;
propofol;
rocuronium
- MeSH:
Adult;
Anesthesia;
Anesthesia, General;
Anesthesia, Intravenous;
Anesthetics, Inhalation;
Charcot-Marie-Tooth Disease*;
Fentanyl;
Fractures, Compression;
Humans;
Intubation, Intratracheal;
Malignant Hyperthermia;
Propofol*;
Spine
- From:Korean Journal of Anesthesiology
2003;44(5):721-724
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
This case involves a 43-year-old man who had been diagnosed as having Charcot-Marie-Tooth disease (CMTD) 9 years ago and was scheduled to undergo posterior fusion of its spine due to a compression fracture. General anesthesia using propofol was selected as the anesthetic method, in order to avoid the occurrence of malignant hyperthermia due to inhalation anesthetics. The patient was given 100 mg of propofol for anesthetic induction, and then propofol was infused at a rate of 4-5 mg/kg/h with intermittent administration of fentanyl for anesthetic maintenance. Rocuronium 50 mg was injected for endotracheal intubation, and then rocuronium 10 mg was injected at 45 min intervals. There was no delay in awakening, and the patient experienced no problems postoperatively. Intravenous anesthesia using propofol is thought to be a safe and effective method of anesthesia for patients with CMTD.
